Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

ZD-0473 associated with manageable toxicity, activity in hormone-refractory prostate cancer

Feb. 25, 2002

Researchers at the University of Edinburgh synthesize anticancer ruthenium complexes

Feb. 22, 2002

Compounds for damaging newly formed vascular endothelium disclosed by Angiogene

Feb. 22, 2002

Zevalin therapeutic regimen approved for NHL

Feb. 22, 2002

First multiple-dose clinical study of ERA-923 in healthy postmenopausal women

Feb. 22, 2002

Inhibitors of cyclin-dependent kinases with potential as antitumor agents

Feb. 21, 2002

Casodex 150 mg receives priority review in early-stage prostate cancer

Feb. 21, 2002

Novel anticancer therapy target validated at Cell Therapeutics

Feb. 21, 2002

ImmunoGen and Millennium sign exclusive product license

Feb. 21, 2002

Beyond Genomics and diaDexus enter cancer diagnostic and drug discovery agreement

Feb. 21, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...